期刊文献+

应用超临界快速膨胀法制备厚朴SCF-CO_2萃取物纳米液 被引量:2

Preparation of nanopaticles of SCF-CO_2 extraction of Magnolia officinalis
原文传递
导出
摘要 目的:应用超临界快速膨胀技术制备中药厚朴超临界CO2流体(SCF-CO2)萃取物纳米液,并结合正交实验优选最佳工艺。方法:以平均粒径、厚朴酚、和厚朴酚的总酚含量为考察指标,采用L9(34)正交实验,对影响RESS制备厚朴纳米液的因素(萃取温度、萃取压力、喷嘴孔径、预膨胀温度)进行优选。结果:最佳制备条件为:萃取温度50℃,萃取压力25MPa,喷嘴孔径200μm,预膨胀温度30℃;此条件下得到乳白色澄清纳米液,平均粒径为303.50nm,纳米液中总酚含量为0.172g·L-1,低温密封放置1个月内仍保持稳定。结论:该技术稳定可行,且操作温度低,工艺流程简单,对环境无污染,无有机溶剂残留。 Objective:To prepare nano-particles of SCF-CO2 extraction of Magnolia officinalis with rapid expansion of supercritical solution(RESS) and optimize the preparation procedure with orthogonal experiment.Method:The preparation procedures were optimized by orthogonal test L(934) with the mean particle size and the amounts of total-phenol as indexes.Factors of the extraction pressure and temperature,diameter of nozzle,pre-expansion temperature were evaluated for their effects on preparation process.Result:The op...
出处 《中国中药杂志》 CAS CSCD 北大核心 2009年第4期390-393,共4页 China Journal of Chinese Materia Medica
基金 国家自然科学基金项目(NSFC30572377) 广东省科技计划攻关项目(2005B33001009)
关键词 SCF-CO2 超临界快速膨胀 厚朴 纳米液 SCF-CO2 RESS Magnolia officinalia nanoparticles
  • 相关文献

参考文献3

二级参考文献22

  • 1毛里纳(Mao LN) 尹嘉(Yin J).厚朴酚抗菌作用的实验研究[J].中国公共卫生学报(Chin J Public Health),1999,18(4):215-216.
  • 2Karageuzyan KG, Vartanyan GS, Agadjanov MI, et al. Restoration of the disordered glucose-faty acid cycle in alloxan-diabetic rats by trihydroxyoctade-cadienoic acids form bryonia alba, a native Armenian medicinal plant[J]. Planta Med,1998,64(5):417-422.
  • 3Heras BDL, Hoult JRS. Non-cytotoxic inhibition of macrophage eicosanoid bioxynthesis and effects on leukocyte functions and reactive oxygen species of two novel anti-inflammatory plant diterpenoids[J].Planta Med, 1994,60(6) : 501-506.
  • 4Enderson LM,Chappell JB, Jones OT. Superoxide generation is inhibited by phospholipase A2 inhibitors. Role for phospholipase A2 in the activation of the NADPH oxidase[J]. Biochem J, 1989,264(1) :249-255.
  • 5Dana R, Malech HL, Levy R. The requirement for phospholipase A2 for activation of the assembled NADPH oxidase in human neutrophils[J]. Biochem J, 1994,297(Pt 1):217-223.
  • 6Dana R, Leto TL, Malech ML, et al. Essential requirement of cytosolic phospholipase A2 for activation of the phagocyte NADPH oxidase[J]. J Biol Chem,1998,273(1):441-445.
  • 7Hamasaki Y, Kobayashi I, Masafumi Z, et al. Magnolol inhibits leukotriene synthesis in rat basophilic leukemia-2H3 cells[J]. Planta Med, 1999,65(3) :222-226.
  • 8Mollapour E, Linch DC, Roberts PJ. Activation and priming of neutrophil nicotinamide adenine dinucleotide phosphate oxidase and phospholipase A2 are dissociated by inhibitors of the kinases p42ERK2 and p38SAPK of cytosolic and calcium-independent phospholipase A2[J].Blood,2001,97(8) :2469-2477.
  • 9Kocan GP, Partis RA, Muella RA, et al. Contrasting effects of two arachidonate 5-lipoxygenase inhibitors on formyl-mathionyl-leucylphelaylalanine (fMLP) and complement fragment 5a induced human neuphotril superoxide generation[J].Biochem Pharmacol,1994,47(6) : 1029-1037.
  • 10Subramaniam B, Rajewski RA, Snavely K. Pharmaceutical processing with supercritical carbon dioxide [J]. J Pharm Sci, 1997, 86 (8): 885-890.

共引文献83

同被引文献34

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部